← FDA Drug Approvals (Drugs@FDA)

SCOPOLAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN TECHNOLOGIES · Approved 2019-06-19

Drug application

FDA Application #
ANDA203753
Application type
Abbreviated New Drug Application (Generic)
Brand name
SCOPOLAMINE
Generic name
SCOPOLAMINE
Active ingredients
SCOPOLAMINE
Dosage form
SYSTEM
Route
TRANSDERMAL
Marketing status
Prescription
Sponsor
MYLAN TECHNOLOGIES
Manufacturer
Mylan Pharmaceuticals Inc.
First approval
2019-06-19

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown